Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1997-3-10
|
pubmed:abstractText |
The aim of this study has been to investigate the plasma endothelin-1 (ET-1) levels in adult patients with proven Addison's disease (AD). Plasma ET-1 levels were measured in 29 subjects (17 males and 12 females, aged between 20 and 54 years): 15 of them were patients with AD and 14 were sex- and age-matched normal subjects, used as a control group. All patients with AD have been studied under basal conditions and nine of them also after 2 weeks on oral corticosteroid therapy (individual cortisol dosage ranging from 25 to 37.5 mg/day and 0.1 mg/day 9 alpha-fluorohydrocortisone). Extracted plasma ET-1 was determined by a specific radioimmunoassay using rabbit endothelin antisera. Mean ET-1 values in the patients with AD were three times higher than in normal subjects (21.09 +/- 4.38 pg/ml vs 6.72 +/- 1.74 pg/ml; p < 0.0001). Plasma ET-1 levels assayed in the patients with AD after 2 weeks of corticosteroid therapy were significantly decreased (14.47 +/- 3.7 pg/ml vs 22.8 +/- 5.2 pg/ml; -37%; p < 0.001) compared to values in untreated patients. However, the plasma ET-1 values obtained following corticosteroid therapy were still significantly higher (p < 0.001) than those detected in the control subjects. These results clearly indicate that patients with untreated AD have increased circulating ET-1 levels that may be reduced by short-term corticosteroid therapy.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Endothelin-1,
http://linkedlifedata.com/resource/pubmed/chemical/Fludrocortisone,
http://linkedlifedata.com/resource/pubmed/chemical/Hydrocortisone,
http://linkedlifedata.com/resource/pubmed/chemical/Immune Sera,
http://linkedlifedata.com/resource/pubmed/chemical/Mineralocorticoids
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0804-4643
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
135
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
696-9
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9025715-Addison Disease,
pubmed-meshheading:9025715-Adult,
pubmed-meshheading:9025715-Animals,
pubmed-meshheading:9025715-Anti-Inflammatory Agents,
pubmed-meshheading:9025715-Endothelin-1,
pubmed-meshheading:9025715-Female,
pubmed-meshheading:9025715-Fludrocortisone,
pubmed-meshheading:9025715-Hemodynamics,
pubmed-meshheading:9025715-Humans,
pubmed-meshheading:9025715-Hydrocortisone,
pubmed-meshheading:9025715-Immune Sera,
pubmed-meshheading:9025715-Male,
pubmed-meshheading:9025715-Middle Aged,
pubmed-meshheading:9025715-Mineralocorticoids,
pubmed-meshheading:9025715-Rabbits,
pubmed-meshheading:9025715-Radioimmunoassay,
pubmed-meshheading:9025715-Reference Values
|
pubmed:year |
1996
|
pubmed:articleTitle |
High plasma levels of endothelin-1 in untreated Addison's disease.
|
pubmed:affiliation |
Department of Experimental Medicine and Pathology, University La Sapienza, Rome, Italy.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|